Some Candidate Drugs for Pharmacotherapy of Alzheimer's Disease
Alzheimer's disease (AD; progressive neurodegenerative disorder) is associated with cognitive and functional impairment with accompanying neuropsychiatric symptoms. The available pharmacological treatment is of a symptomatic nature and, as such, it does not modify the cause of AD. The currently...
Saved in:
Main Authors: | Barbara Miziak (Author), Barbara Błaszczyk (Author), Stanisław J. Czuczwar (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comorbid epilepsy and depression-pharmacokinetic and pharmacodynamic drug interactions
by: Barbara Miziak, et al.
Published: (2022) -
Pharmacomodulations around an anti-Alzheimer drug-candidate
by: Sylvain Marc, et al.
Published: (2022) -
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer's Disease
by: Siew Lee Cheong, et al.
Published: (2022) -
Cross-Talk between Amyloid, Tau Protein and Free Radicals in Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy
by: Ryszard Pluta, et al.
Published: (2022) -
Drug Candidates for the Treatment of Alzheimer's Disease: New Findings from 2021 and 2022
by: Sujatha L. Motebennur, et al.
Published: (2023)